Lacebal, Rene R.

HRN: 24-99-99  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/25/2026
COTRIMOXAZOLE 960MG (TAB)
07/25/2026
07/31/2026
PO
960mg
OD
Aplastic Anemia
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Disseminated Systemic Infection    Compliance to guidelines: